Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 332 followers

Latest posts

Last updated about 8 hours ago

Human medicines European public assessment report (EPAR): Evfraxy, denosumab, Date of authorisation: 30/06/2025, Revision: 2, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Evfraxy, denosumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Hemangiol, propranolol, Date of authorisation: 23/04/2014, Revision: 8, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Hemangiol, propranolol, Date of authorisation...

Human medicines European public assessment report (EPAR): Balversa, erdafitinib, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Balversa, erdafitinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 75, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation...

EMEA-000925-PIP02-10

about 8 hours ago

EMEA-000925-PIP02-10

Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation: 17/11/2025, Revision: 1, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Lynkuet, elinzanetant, Date of authorisation...

EMEA-000924-PIP01-10

about 8 hours ago

EMEA-000924-PIP01-10

Human medicines European public assessment report (EPAR): Qalsody, tofersen, Date of authorisation: 29/05/2024, Revision: 3, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Qalsody, tofersen, Date of authorisation...

Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 24, Status: Authorised

about 8 hours ago

Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation...

EMEA-000923-PIP02-10

about 8 hours ago

EMEA-000923-PIP02-10

Human medicines European public assessment report (EPAR): Ikervis, ciclosporin, Date of authorisation: 19/03/2015, Revision: 12, Status: Authorised

about 9 hours ago

Human medicines European public assessment report (EPAR): Ikervis, ciclosporin, Date of authorisation...

EMEA-000922-PIP02-10

about 9 hours ago

EMEA-000922-PIP02-10